title: Advanced glycation end products: possible link between metabolic syndrome and periodontal diseases.
abstract: On a planetary scale, Metabolic Syndrome (MetS)is the third cause of inability after malnutrition and nicotinism, even higher than water shortage and sedentariness. In the  USA, the prevalence is estimated at over 25 percent of the population; in Italy, it involves approximately 25 percent of men and even 27 percent of women. These are very high figures, corresponding to approximately 14 million affected individuals. The prevalence is alarming and must not be underestimated, particularly in the dental field, where more than one patient out of four sitting in a dentist chair is affected. The etiology of periodontal disease has not yet been clarified, and recently the idea to consider it as a multifactor pathology has been developed. Cofactors such as  the formation of free radicals of oxygen (ROS), oxidative stress, lipid peroxidation, and formation of glycation end-products (AGEs) probably play an important role in the onset of periodontal disease. The AGEs are compounds physiologically produced by the cells. However, they accumulate and cause pro-inflammatory conditions, when the cellular clearance fails, or in hyperglycemic and oxidative states. All these conditions can be clinically summarized as Metabolic Syndrome. The purpose of this literature review is to establish a relationship between two pathologies with very high prevalence: Metabolic Syndrome and Periodontal Disorder. The literature seems to have clarified that MetS involves a pro-oxidation status, which induces AGE formation. AGEs play a very important role in the course and severity of periodontal diseases.
authors.affiliation: Department of Health Sciences, University of L'Aquila, Faculty of Medicine and Surgery, L'Aguila, Italy. davidepietropaoli@gmail.com
authors.forename: D
authors.initials: D
authors.lastname: Pietropaoli
authors.forename: A
authors.initials: A
authors.lastname: Monaco
authors.forename: R
authors.initials: R
authors.lastname: Del Pinto
authors.forename: M G
authors.initials: MG
authors.lastname: Cifone
authors.forename: G
authors.initials: G
authors.lastname: Marzo
authors.forename: M
authors.initials: M
authors.lastname: Giannoni
mesh_terms: D005260:Female; D017127:Glycation End Products, Advanced / Q000502:physiology*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000378:metabolism; D010510:Periodontal Diseases / Q000209:etiology*; D017382:Reactive Oxygen Species / Q000378:metabolism; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000502:physiology
chemical_list: D017127:Glycation End Products, Advanced; D017382:Reactive Oxygen Species; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic